Subject search results
8 Document(s) [ Subject: Pharmaceutical industry ]
Committee: | House Insurance | |
Title: | Interim Report | |
Subjects: | Flood insurance | Health insurance | Insurance industry | Insurance, Texas Department of | Medical bill balance billing | Patient Protection and Affordable Care Act | Pharmaceutical industry | Texas Health Insurance Risk Pool | Texas Windstorm Insurance Association | Vehicle insurance | | |
Library Call Number: | L1836.86 In7 | |
Session: | 86th R.S. (2019) | |
Online version: | View report [83 pages File size: 5,196 kb] | |
Charges: | This report should address the charges below. | |
1. | Monitor the agencies and programs under the Committee's jurisdiction and oversee the implementation of relevant legislation passed by the 86th Legislature. Conduct active oversight of all associated rulemaking and other governmental actions taken to ensure intended legislative outcome of all legislation, including the following:
|
|
2. | Study the adequacy of the state’s insurance laws on regulating the introduction of insurtech products into the Texas insurance market. Include in the study the impact of big data, blockchain, internet of things, and artificial intelligence technologies on industry practices such as claims handling, underwriting, and policy writing. Study whether these technologies present challenges for any of the state’s insurance laws, including the state’s anti-discrimination, data privacy, anti-rebate, and licensing laws and regulations. Additionally, examine the pros and cons of adopting a regulatory sandbox and consider sandbox programs that are implemented in other states. | |
3. | Monitor the State Auditor's review of agencies and programs under the Committee's jurisdiction. The Chair shall seek input and periodic briefings on completed audits for the 2019 and 2020 fiscal years and bring forth pertinent issues for full committee consideration. | |
Committee: | House Human Services | |
Title: | Interim Report | |
Subjects: | Adoption | Assisted living facilities | Child abuse | Child abuse prevention | Child Protective Services | Early childhood intervention | Emergency management | Family preservation | Foster care | Hurricane Harvey | Long-term care | Managed care | Medicaid | Medicaid program management | Mentally ill persons | Natural disasters | Nursing homes | Pharmaceutical industry | Prescription drugs | State supported living centers | Substance abuse | Tropical storms | | |
Library Call Number: | L1836.85 H88 | |
Session: | 85th R.S. (2017) | |
Online version: | View report [50 pages] | |
Charges: | This report should address the charges below. | |
1. | Study the impact of Hurricane Harvey and the response to the storm on individuals living in long-term care facilities, assisted living facilities, state supported living centers, licensed community group homes, and children in the foster care system. Identify and recommend necessary solutions to ensure appropriate disaster-related protocols are in place to keep vulnerable Texans protected. Also, identify any challenges state agencies experienced in responding to the storm or during recovery efforts. | |
2. | Review the history and any future roll-out of Medicaid Managed Care in Texas. Determine the impact managed care has had on the quality and cost of care. In the review, determine: initiatives that managed care organizations (MCOs) have implemented to improve quality of care; whether access to care and network adequacy contractual requirements are sufficient; and whether MCOs have improved the coordination of care. Also determine provider and Medicaid participants’ satisfaction within STAR, STAR Health, Star Kids, and STAR+Plus managed care programs. In addition, review the Health and Human Services Commission's (HHSC) oversight of managed care organizations, and make recommendations for any needed improvement. | |
3. | Examine the survey process for nursing facilities to determine any duplication of government regulations. Consider recommendations to reduce duplication while ensuring patient safety is preserved. | |
4. | Review the availability of prevention and early intervention programs and determine their effectiveness in reducing maltreatment of children. In addition, review services available to children emancipating out of foster care, as well as services available to families post-adoption. Determine if current services are adequately providing for children's needs and meeting the objectives of the programs. While reviewing possible system improvements for children, follow the work of the Supreme Court of Texas Children's Commissions' Statewide Collaborative of Trauma-Informed Care to determine how trauma-informed care impacts outcomes for children. | |
5. | Analyze the prevalence of children involved with Child Protective Services (CPS) who have a mental illness and/or a substance use disorder. In addition, analyze the prevalence of children involved with CPS due to their guardian's substance abuse or because of an untreated mental illness. Identify methods to strengthen CPS processes and services, including efforts for family preservation; increasing the number of appropriate placements designed for children with high needs; and ensuring Texas Medicaid is providing access to appropriate and effective behavioral health services. (Joint charge with the House Committee on Public Health) | |
6. | Monitor the HHSC's implementation of Rider 219 in Article II of the General Appropriations Act related to prescription drug benefit administration in Medicaid. Analyze the role of pharmacy benefit managers in Texas Medicaid. | |
7. | Monitor the agencies and programs under the Committee’s jurisdiction and oversee the implementation of relevant legislation passed by the 85th Legislature. In conducting this oversight, the committee will also closely monitor the implementation of H.B. 4 (85R), H.B. 5 (85R), H.B. 7 (85R), and S.B. 11 (85R). | |
Committee: | House Business and Industry | |
Title: | Interim Report | |
Subjects: | Corporate governance | Death benefits | Electronic security | Homeowners' associations | Independent contractors | International trade | Pharmaceutical industry | Pharmacies | Physicians | Prescription drug costs | Risk Management, State Office of | Small businesses | State agencies | Transportation network companies | Welfare-to-work | Workers' compensation | | |
Library Call Number: | L1836.84 B964 | |
Session: | 84th R.S. (2015) | |
Online version: | View report [67 pages] | |
Charges: | This report should address the charges below. | |
1. | Study Texas businesses' utilization of the Federal Work Opportunity Tax Credit, and the associated state tax refund under Subchapter H, Labor Code, in employing those who are receiving government benefits and/or have consistently faced significant barriers to employment. Conduct a cost/benefit analysis of the tax credit vis-a-vis savings in federal and state public assistance programs. Make recommendations to remove any unnecessary administrative obstructions and expand Texas business owners' use of the program. | |
2. | Identify and address potential gaps in Texas businesses’ cybersecurity policies and ensure that Texans’ personal information held by these businesses is secure. | |
3. | Evaluate how Texas can support shared economy growth in the state. Determine how the state can ensure customer security and satisfaction as well as consumer protections without enacting burdensome regulations. Additionally, study the effects of a growing portion of the state's workforce seeking full-time vs. supplemental part-time employment with related technology-based businesses. Analyze recent debate and legal precedent regarding the classification of these employees. | |
4. | Examine the regulatory powers of property owners associations, and the procedures available to home owners when an association restricts individual or property rights. Review current best practices to help clarify the balance of property rights, transparency in governance, and the best interests of property owners in the state. | |
5. | Study the impact of recent Texas cases related to the rights and remedies of shareholders of Texas corporate forms, including the impact of those decisions on the legal rights of both Texas corporations and shareholders and any impact on the Texas business climate. | |
6. | Study the requirement for state agencies and entities to purchase insurance through the State Office of Risk Management (SORM), and the agencies and entities that are exempt from this requirement. Examine the costs and benefits of each approach, and the waiver process by which SORM can allow agencies to purchase insurance on their own. | |
7. | Study the following aspects of the designated doctor process in the Texas workers' compensation system: a. the Division of Workers' Compensation's (DWC's) processes for educating, monitoring, and evaluating designated doctors; b. whether the DWC requires additional authority to regulate designated doctors or entities providing services for designated doctors; and c. any unique issues with "traveling" designated doctors. | |
8. | Examine the adequacy of benefits for injured employees in the Texas workers' compensation system who qualify for Lifetime Income Benefits, and for the beneficiaries of employees who receive Death Benefits. In particular, examine the application of benefit caps for those benefit types and the termination of Death Benefits to surviving spouses on remarriage. | |
9. | Analyze recent data attributing the decline in domestic manufacturing to a consistent trade deficit caused by steady increases in net imports. Study how expanding trade and investing in manufacturing communities’ partnerships can grow the state's skilled workforce and production as well as increase net exports and develop a trade balance. (Joint charge with the House Committee on International Trade & Intergovernmental Affairs) | |
10. | Conduct legislative oversight and monitoring of the agencies and programs under the committee’s jurisdiction and the implementation of relevant legislation passed by the 84th Legislature. In conducting this oversight, the committee should: a. consider any reforms to state agencies to make them more responsive to Texas taxpayers and citizens; b. identify issues regarding the agency or its governance that may be appropriate to investigate, improve, remedy, or eliminate; c. determine whether an agency is operating in a transparent and efficient manner; and d. identify opportunities to streamline programs and services while maintaining the mission of the agency and its programs. | |
Supporting documents | ||
Committee: | House Business and Industry | |
Title: | Committee meeting handouts and testimony, March 23, 2016 (Lawsuits, dispute resolution, oversight, insurance purchases by state agencies) | |
Library Call Number: | ||
Session: | 84th R.S. (2015) | |
Online version: | View document [257 pages File size: 17,549 kb] | |
Committee: | House Public Health | |
Title: | Interim Report | |
Subjects: | Border crossings | Border issues | Border security | Dental Examiners, Texas State Board of | Dentists | Ebola | Food and Drug Administration, U.S. | Foster care | Immunizations | Medical records | Pharmaceutical industry | Pharmacies | Pregnancy | Prenatal care | Prescription drugs | Psychoactive drugs | Substance abuse | Unaccompanied minors | Undocumented immigrants | Workers' compensation | Workforce Commission, Texas | | |
Library Call Number: | L1836.83 H349h | |
Session: | 83rd R.S. (2013) | |
Online version: | View report [82 pages] | |
Charges: | This report should address the charges below. | |
1. | Assess the prevalence of nonmedical prescription drug use in the state (including opioid analgesics, stimulants, tranquilizers, and sedatives). Identify adverse health impacts. Recommend strategies to curb emerging substance abuse trends among children, pregnant women, and adults, as well as to reduce health care costs and mortality. | |
2. | Study and make recommendations for improvements to the licensing, regulation, and monitoring of compounding pharmacies, including a review of the joint cooperative efforts between the Texas State Board of Pharmacy, Department of State Health Services, and U.S. Food and Drug Administration. Consider the impact of the passage of SB 1100, 83rd R.S., additional appropriations made by the 83rd Legislature to strengthen inspections, and any relevant federal legislation. | |
3. | Identify strategies to support the efficient exchange of electronic health information with Texas Health and Human Services enterprise agencies. Examine legal and technical issues around the accessibility of information held in registries maintained by state agencies to authorized health care providers. Identify issues related to health information exchange and providers' liability, as well as concerns related to transitioning patient data in cases where a provider selects a new electronic health record vendor. | |
4. | Examine the current practice for dispensation of biologic and follow-on biologic (biosimilar) pharmaceutical products in our state. Review any practices for interchangeability of drugs that might pertain to these particular medicines. Review and make recommendations regarding the substitution of biosimilar and biologic medicines. | |
5. | Monitor transition of the state's immunization registry to a new system. Determine whether the registry can be better utilized to prevent and/or respond to communicable disease outbreaks, including pertussis. Identify potential factors contributing to the rise in the number of pertussis cases and strategies to prevent future outbreaks. | |
6. | Conduct legislative oversight and monitoring of the agencies and programs under the committee’s jurisdiction and the implementation of relevant legislation passed by the 83rd Legislature, including HB 15, 83rd R.S.. In conducting this oversight, the committee should: a. consider any reforms to state agencies to make them more responsive to Texas taxpayers and citizens; b. identify issues regarding the agency or its governance that may be appropriate to investigate, improve, remedy, or eliminate; c. determine whether an agency is operating in a transparent and efficient manner; and d. identify opportunities to streamline programs and services while maintaining the mission of the agency and its programs. | |
Committee: | Senate Health Services | |
Title: | Interim Report | |
Library Catalog Title: | Report to the 77th Legislature / Texas Senate Health Committee. | |
Subjects: | Biological weapons | Biotechnology industry | Children's Health Insurance Program | Cloning | Dentists | Ethics | Genetic research and testing | Health care providers | Immunizations | Managed care | Medicaid | Medical privacy | Medical records | Nurses | Nursing shortages | Pharmaceutical industry | Pharmacists | Physicians | Privacy | State employee turnover | Telemedicine | | |
Library Call Number: | L1836.76 h35 | |
Session: | 76th R.S. (1999) | |
Online version: | View report [356 pages File size: 6,500 kb] | |
Charges: | This report should address the charges below. | |
1. | Evaluate the changes in the Medicaid system since the beginning of Medicaid reform. The Committee shall assess reform efforts in light of the original goals for implementation of Medicaid managed care, as well as the impact of Medicaid managed care on patient outcomes, cost implications to the state, and the impact on traditional providers of indigent care. The Committee shall also specifically evaluate the ability of Medicaid managed care organizations and the state to manage chronic illnesses and develop specific strategies for disease management for certain populations. | |
2. | Inventory and analyze the amount and type of research related to pharmaceuticals, biotechnology and genetics currently occurring in Texas to maximize the benefits to Texans in these fields. The Committee shall also examine the ethical implications associated with pharmaceuticals, genetic and biotechnology research. | |
3. | Review the type, amount, availability, and use of patient-specific medical information, including prescription data, and current statutory and regulatory provisions governing its availability. The report shall explore if statutory and regulatory provisions are consistent and adequately enforced. | |
4. | Study impacts of the degree of choice granted physicians to administer immunizations to children under the Vaccinations For Children (VFC) Program. The Committee shall focus on the health and fiscal implications to the public and private sectors of granting choices to physicians where more than one manufacturer produces the same vaccine at an equivalent price. | |
5. | Assess the preparedness of the Texas health care workforce to meet the health care needs of Texans beyond the year 2000, including methods to retain Texas-trained medical personnel. The Committee shall evaluate the availability of health care providers in rural and urban areas. The Committee shall also review the oversight of medical procedures performed by medical residents and disclosure provided to patients prior to treatment. | |
6. | Monitor the implementation of SB 445, 76th R.S. relating to the Children's Health Insurance Program. | |
Committee: | House Public Health | |
Title: | Interim Report | |
Library Catalog Title: | House Committee on Public Health, Texas House of Representatives interim report, 2000 : a report to the House of Representatives, 77th Texas Legislature. | |
Subjects: | Children's health insurance | Children's Health Insurance Program | e-commerce | Emergency medical services | Health care | Hospitals | Indigent health care | Internet | Managed care | Medicaid | Nonprofit hospitals | Pharmaceutical industry | Pharmacists | Prescription drug costs | Prescription drugs | Public health | State government contracts | Telemedicine | Trauma centers | | |
Library Call Number: | L1836.76 h349h | |
Session: | 76th R.S. (1999) | |
Online version: | View report [275 pages File size: 10,000 kb] | |
Charges: | This report should address the charges below. | |
1. | Review the role of the pharmaceutical industry in the delivery of health care in Texas. The review should identify pharmaceutical cost-drivers and opportunities to reduce costs, assess the role of pharmacy benefit managers and pharmacies, and address patient-specific issues, as well as other issues identified by the committee. | |
2. | Review issues related to the increased use of new technologies in the delivery of health care. The review should identify opportunities and risks associated with the sale of medical devices and drugs over the Internet, the feasibility of expanding telemedicine to improve care in underserved areas, and regulatory and privacy issues presented by these new technologies. | |
3. | Evaluate the role and potential of disease management in public health programs that serve chronically ill populations. | |
4. | Study issues arising from hospital system sales, conversions, partnerships and mergers, including the impact on health care in medically underserved and rural communities and on the level of charity care provided. | |
5. | Examine the requirements imposed on emergency medical services providers in rural areas. Determine whether individual requirements encourage or hinder the provision of services. | |
6. | Conduct active oversight of the agencies under the committee's jurisdiction, including the Children's Health Insurance Program, the restructuring of health and humans service agencies under HB 2641, 76th R.S., and the Medicaid managed care program. | |
Committee: | House Public Health | |
Title: | Interim report | |
Library Catalog Title: | Interim report to the 72nd Texas Legislature / Committee on Public Health. | |
Subjects: | At-risk youth | Health maintenance organizations | Medical research | Pharmaceutical industry | Pharmacists | Prescription drug costs | Prescription drugs | Substance abuse | Texas Pharmacy Act | Underage drinking | | |
Library Call Number: | L1836.71 h349 | |
Session: | 71st R.S. (1989) | |
Online version: | View report [39 pages File size: 1,612 kb] | |
Charges: | This report should address the charges below. | |
1. | To study substance abuse problems of Texas youth. | |
2. | To study the benefits and public necessity of licensing and regulating medical laboratories in Texas, including the relative merits of state regulation versus federal regulation. | |
3. | To study prescription drug programs provided under health insurance policies or contracts and employee benefit plans. |
Information on this website is provided as a public service by the Legislative Reference Library. The Legislative Reference Library makes no representation as to its completeness or accuracy and makes no warranty in regard to its use. Users assume all risk of reliance on the information included on this site.